{
  "id": "everyday#do_not_do_c8b87ea7",
  "title_en": "General — Do Not Do",
  "title_vi": "General — Do Not Do",
  "text_en": "500 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders 6C44.Z Disorder due to use of sedatives, hypnotics or anxiolytics, unspecified 6C45.Z Disorder due to use of cocaine, unspecified 6C46.Z Disorder due to use of stimulants, including amfetamines, methamfetamine and methcathinone, unspecified 6C47.Z Disorder due to use of synthetic cathinones, unspecified 6C48.Z Disorder due to use of caffeine, unspecified 6C49.Z Disorder due to use of hallucinogens, unspecified 6C4A.Z Disorder due to use of nicotine, unspecified 6C4B.Z Disorder due to use of volatile inhalants, unspecified 6C4C.Z Disorder due to use of MDMA or related drugs, including MDA, unspecified 6C4D.Z Disorder due to use of dissociative drugs, including ketamine and PCP, unspecified 6C4E.Z Disorder due to use of other specified psychoactive substance, including medications, unspecified 6C4F.Z Disorder due to use of multiple specified psychoactive substances, unspecified 6C4G.Z Disorder due to use of unknown or unspecified psychoactive substances, unspecified 6C4H Disorders due to use of non-psychoactive substances Disorders due to use of non-psychoactive substances are characterized by the pattern and consequences of non-psychoactive substance use. Non-psychoactive substances include laxatives, growth hormone, erythropoietin and non-steroidal anti-inflammatory drugs. They may also include proprietary or over-the-counter medicines and folk remedies. Disorders due to use of non-psychoactive substances do not include disorders related to psychoactive substances such as anabolic steroids, antidepressants, medications with anticholinergic properties (e.g. benztropine), and some antihistamines. These should be classified under 6C4E Disorders due to use of other specified psychoactive substance, including medications. 6C4H.0 Episode of harmful use of non-psychoactive substances Essential (required) features • An episode of use of a non-psychoactive substance that has caused clinically significant damage to a person’s physical health or mental health is required for diagnosis. • Harm to the health of the individual occurs due to the direct or secondary toxic effects of the non-psychoactive substance on body organs and systems, or a harmful route of administration. • The harm to health is not better accounted for by a medical condition not caused by the substance or by another mental disorder. Substance-induced mental disorders | Disorders due to use of non-psychoactive substances Disorders due to substance use or addictive behaviours 501 Note: harm to physical health includes acute health problems resulting from non-psychoactive substance use such as dehydration or dyslipidemia,",
  "gloss_vi": "500 clinical descriptions and diagnostic requirements for icd-11 mental, behavioural or neurodevelopmental disorders 6c44.z disorder due to use of sedatives, hypnotics or anxiolytics, unspecified 6c45.z disorder due to u...",
  "source": "Everyday Essentials",
  "url": "",
  "lang": "en",
  "axes": {
    "type": [
      "clinical",
      "everyday"
    ],
    "condition": [
      "General"
    ],
    "clinical_section": [
      "do_not_do"
    ],
    "life_topics": [],
    "advice_section": [
      "sleep_hygiene"
    ],
    "audience": [],
    "risk_band": "low"
  },
  "index_text": "General — Do Not Do General — Do Not Do 500 Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural or Neurodevelopmental Disorders 6C44.Z Disorder due to use of sedatives, hypnotics or anxiolytics, unspecified 6C45.Z Disorder due to use of cocaine, unspecified 6C46.Z Disorder due to use of stimulants, including amfetamines, methamfetamine and methcathinone, unspecified 6C47.Z Disorder due to use of synthetic cathinones, unspecified 6C48.Z Disorder due to use of caffeine, unspecified 6C49.Z Disorder due to use of hallucinogens, unspecified 6C4A.Z Disorder due to use of nicotine, unspecified 6C4B.Z Disorder due to use of volatile inhalants, unspecified 6C4C.Z Disorder due to use of MDMA or related drugs, including MDA, unspecified 6C4D.Z Disorder due to use of dissociative drugs, including ketamine and PCP, unspecified 6C4E.Z Disorder due to use of other specified psychoactive substance, including medications, unspecified 6C4F.Z Disorder due to use of multiple specified psychoactive substances, unspecified 6C4G.Z Disorder due to use of unknown or unspecified psychoactive substances, unspecified 6C4H Disorders due to use of non-psychoactive substances Disorders due to use of non-psychoactive substances are characterized by the pattern and consequences of non-psychoactive substance use. Non-psychoactive substances include laxatives, growth hormone, erythropoietin and non-steroidal anti-inflammatory drugs. They may also include proprietary or over-the-counter medicines and folk remedies. Disorders due to use of non-psychoactive substances do not include disorders related to psychoactive substances such as anabolic steroids, antidepressants, medications with anticholinergic properties (e.g. benztropine), and some antihistamines. These should be classified under 6C4E Disorders due to use of other specified psychoactive substance, including medications. 6C4H.0 Episode of harmful use of non-psychoactive substances Essential (required) features • An episode of use of a non-psychoactive substance that has caused clinically significant damage to a person’s physical health or mental health is required for diagnosis. • Harm to the health of the individual occurs due to the direct or secondary toxic effects of the non-psychoactive substance on body organs and systems, or a harmful route of administration. • The harm to health is not better accounted for by a medical condition not caused by the substance or by another mental disorder. Substance-induced mental disorders | Disorders due to use of non-psychoactive substances Disorders due to substance use or addictive behaviours 501 Note: harm to physical health includes acute health problems resulting from non-psychoactive substance use such as dehydration or dyslipidemia, 500 clinical descriptions and diagnostic requirements for icd-11 mental, behavioural or neurodevelopmental disorders 6c44.z disorder due to use of sedatives, hypnotics or anxiolytics, unspecified 6c45.z disorder due to u..."
}